Insider Transactions Reported by 13 Insiders of ImmunityBio, Inc.

Symbol
IBRX on Nasdaq
Location
San Diego, CA

There are no Buy or Sell transactions made by insiders since 10 Jan 2025

ImmunityBio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
PATRICK SOON-SHIONG Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner $240,624,333 22 Feb 2025
Barry J. Simon Director $11,153,940 22 Feb 2025
Richard Adcock CEO & President, Director $1,738,437 31 Dec 2025
John C. Thomas Former Director $1,086,143 31 Dec 2021
David C. Sachs Chief Financial Officer $754,401 31 Dec 2025
REGAN J. LAUER Chief Accounting Officer $404,887 22 Feb 2025
Bruce Wendel Director 12 Dec 2025
LINDA MAXWELL Director 18 Jun 2025
Christobel Selecky Director 18 Jun 2025
Wesley Clark Director 18 Jun 2025
John Owen Brennan Director 11 Jun 2024
MICHAEL D. BLASZYK Director 18 Jun 2025
Cheryl Cohen Director 18 Jun 2025

Recent Insider Transactions by Companies or Individuals for ImmunityBio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.